Director New Product Development, Market Research, And Business Development
CurrentI am leading the organization in charge of new product planning and launch, market intelligence on therapeutic advances, product update, and impact of public policy, business development and alliance management, managing a portfolio of high-quality generics and biosimilars, and providing business analysis and guidance to company leadership team. Major accomplishments include:• Rebuilt the NPP and MR from ground in summer 2012• Strengthen the affiliate NPP through recruiting high-caliber candidates and securing resources for quality work and meaningful impact• Beyond traditional market intelligence and research, we provided actionable insights synthesized from multiple sources and laid out recommendations and action steps for senior leaders• Built up management capability for branded generics and business development for the affiliate. Nowadays, we manage three BD alliances and a portfolio of both small and large molecules• Provided tailored analysis report on hot subjects on C-executive’s requests (examples: private hospitals in China, what drives top multi-national company’s growth in China and what Lilly can learn, best practice in launching new products in China)• Won multiple global market research awards based on work quality and business impact in 2013 and 2014• Through our work and impact, we started changing people’s perception that market research is just a “supportive function” or NPP is “not relevant to affiliate’s business as product launches are years away”. Today, senior management is emphasizing evidence-based decisions and how critical NPP is in ensuring timely launch and commercial success